Nektar Therapeutics | NKTR - Equity Capital And Reserves


Nektar Therapeutics reported $85.09M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Agios Pharmaceuticals USD 1.19B 91.22M Dec/2025
ALKERMES USD 1.82B 85.86M Dec/2025
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Amgen USD 8.66B 961M Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
BioCryst Pharmaceuticals USD -387.89M 33.7M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Cara Therapeutics USD 32.93M 41M Jun/2025
Cipla INR 329.19B 16.3B Sep/2025
Dr.Reddys Laboratories INR 375.76B 13.67B Dec/2025
Eisai JPY 889.64B 35.21B Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Esperion Therapeutics USD -451.36M 17.85M Sep/2025
Exelixis USD 2.16B 619K Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Grifols EUR 6.08B 34.72M Sep/2025
Halozyme Therapeutics USD 48.81M 455.1M Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Ironwood Pharmaceuticals USD -264.16M 44M Sep/2025
Karyopharm Therapeutics USD -269.26M 30.33M Sep/2025
MacroGenics USD 67M 20.38M Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Neurocrine Biosciences USD 3.25B 249.5M Dec/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sarepta Therapeutics USD 1.14B 179.5M Dec/2025
Takeda JPY 7.64T 513.39B Dec/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025
Xencor USD 635.59M 10.27M Dec/2025